Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-06-12
2007-06-12
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C562S445000, C562S553000
Reexamination Certificate
active
11128732
ABSTRACT:
Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
REFERENCES:
patent: 4018912 (1977-04-01), Okamoto et al.
patent: 4018913 (1977-04-01), Okamoto et al.
patent: 4018915 (1977-04-01), Okamoto et al.
patent: 4036955 (1977-07-01), Okamoto et al.
patent: 4041156 (1977-08-01), Okamoto et al.
patent: 4046876 (1977-09-01), Okamoto et al.
patent: 4055636 (1977-10-01), Okamoto et al.
patent: 4055651 (1977-10-01), Okamoto et al.
patent: 4069318 (1978-01-01), Okamoto et al.
patent: 4070457 (1978-01-01), Okamoto et al.
patent: 4071621 (1978-01-01), Okamoto et al.
patent: 4073911 (1978-02-01), Kikumoto et al.
patent: 4074057 (1978-02-01), Kawamatsu et al.
patent: 4096255 (1978-06-01), Kikumoto et al.
patent: 4097591 (1978-06-01), Okamoto et al.
patent: 4104392 (1978-08-01), Okamoto et al.
patent: 4977168 (1990-12-01), Bernat et al.
patent: 5338755 (1994-08-01), Wagnon et al.
patent: 5397801 (1995-03-01), Wagnon et al.
patent: 5481005 (1996-01-01), Wagnon et al.
patent: 5578633 (1996-11-01), Wagnon et al.
patent: 5686628 (1997-11-01), Veale et al.
patent: 6221888 (2001-04-01), Durette et al.
patent: 6291511 (2001-09-01), Durette et al.
patent: 6552216 (2003-04-01), Singh et al.
patent: 6686350 (2004-02-01), Zheng et al.
patent: 6147073 (1995-04-01), None
patent: 2357334 (1974-06-01), None
patent: 2655636 (1977-06-01), None
patent: 0526348 (1993-02-01), None
patent: 9711143.9 (1997-05-01), None
patent: 9714314.3 (1997-07-01), None
patent: 9714316.8 (1997-07-01), None
patent: 9714335.8 (1997-07-01), None
patent: 9722674.0 (1997-10-01), None
patent: 9800680.2 (1998-01-01), None
patent: 9800684.4 (1998-01-01), None
patent: 9800686.9 (1998-01-01), None
patent: WO 92/16549 (1992-10-01), None
patent: WO 94/07815 (1994-04-01), None
patent: WO 94/12181 (1994-06-01), None
patent: WO 95/15973 (1995-06-01), None
patent: WO 96/20725 (1996-07-01), None
patent: WO 96/20949 (1996-07-01), None
patent: WO 96/22966 (1996-08-01), None
patent: WO 97/03094 (1997-01-01), None
patent: WO 98/04247 (1998-02-01), None
patent: WO 98/42656 (1998-10-01), None
patent: WO 98/53814 (1998-12-01), None
patent: WO 98/53817 (1998-12-01), None
patent: WO 98/53818 (1998-12-01), None
patent: WO 98/54207 (1998-12-01), None
patent: WO 99/06436 (1999-02-01), None
patent: WO 99/10312 (1999-03-01), None
patent: WO 99/10313 (1999-03-01), None
English Abstract of JP 4154732, issued May 1992.
Simanis et al.Int. J. Pept. Protein res.(1982) 16(1), pp. 67-70.
Leibritz et al.Tetrahedron(1982) 38(14), pp. 2165-2181.
El-Naggar et al.Acta. Pharm. Jugosl.(1985) 351), pp. 15-22.
Chemical Abstract No. 126040, vol. 74, No. 23 (Jun. 7, 1971).
Chemical Abstract No. 176262, vol. 99, No. 11 (Nov. 21, 1983).
Chemical Abstract No. 210288, vol. 106, No. 25 (Jun. 22, 1987).
Chemical Abstract No. 167952, vol. 108, No. 19 (May 9, 1988).
Chemical Abstract No. 34164, vol. 125, No. (Jul. 15, 1996).
Ashwell Susan
Baudy Reinhardt B.
Dressen Darren B.
Grant Francine S.
Konradi Andrei W.
Elan Pharmaceuticals Inc.
Foley & Lardner LLP
Lukton David
Wyeth
LandOfFree
Carbamyloxy compounds which inhibit leukocyte adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamyloxy compounds which inhibit leukocyte adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamyloxy compounds which inhibit leukocyte adhesion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3879368